In a groundbreaking revelation from the Noom Engagement Report, it is shown that GLP-1 patients who actively engage with Noom’s behavioral change program experience significant weight loss and adhere to their medication plans more effectively. According to the report, these users lose more weight compared to those who are less engaged, showcasing the app’s successful integration with GLP-1 treatments. The findings emphasize Noom’s role in enhancing patient outcomes by coupling psychological insights with medical regimens, offering a comprehensive approach to weight management. Health practitioners see this data as a game-changer, as it underscores the importance of combining lifestyle modifications with pharmaceutical interventions. Noom’s easy-to-use interface and evidence-based strategies empower patients by providing the accountability and support necessary to maintain long-term health changes. This report not only highlights the power of digital health platforms but also sets a precedent for future healthcare innovations.
Yahoo FinanceNew data shows smarter solutions to change-of-mind returns as retailers crack down
August 3, 2026
In a bid to address the rising costs associated with change-of-mind returns, many retailers are implementing stricter policies. However, recent data suggests that a more